Persistent BCG bacilli perpetuate CD4 T effector memory and optimal protection against tuberculosisKAVEH, Daryan A; GARCIA-PELAYO, M. Carmen; HOGARTH, Philip J et al.Vaccine. 2014, Vol 32, Num 51, pp 6911-6918, issn 0264-410X, 8 p.Article

Les réactions cutanées à la tuberculine : technique, valeur, interprétationKAUFMANN, D.Médecine & enfance. 1995, Vol 15, Num 4, pp 117-119, issn 0291-0233Article

MPB70, a unique antigen of Mycobacterium bovis BCGHARBOE, M; NAGAI, S.The American review of respiratory disease. 1984, Vol 129, Num 3, pp 444-452, issn 0003-0805Article

The secretome of a recombinant BCG substrain reveals differences in hypothetical proteinsRODRIGUEZ-ALVAREZ, Mauricio; PALOMEC-NAVA, Iliana D; MENDOZA-HERNANDEZ, Guillermo et al.Vaccine. 2010, Vol 28, Num 23, pp 3997-4001, issn 0264-410X, 5 p.Article

Report of an International collaborative study to establish the first WHO reference reagents for BCG vaccines of three different sub-strainsHO, Mei M; MARKEY, Kevin; RIGSBY, Peter et al.Vaccine. 2011, Vol 29, Num 3, pp 512-518, issn 0264-410X, 7 p.Article

Culture of tubercle bacilli from blood. CommentaryKAI MAN KAM; LOEWENSTEIN, E.The International journal of tuberculosis and lung disease. 2008, Vol 12, Num 12, issn 1027-3719, 1351, 1380-1381 [3 p.]Article

The sensitivity of BCG scar as an indicator of previous vaccination among Sudanese infantsKHEIR, Abdelmoneim E. M; ALHAJ, Abdelmoneim A; IBRAHIM, Samar A et al.Vaccine. 2011, Vol 29, Num 46, pp 8189-8191, issn 0264-410X, 3 p.Article

Recombinant BCG ΔureC hly+ Induces Superior Protection Over Parental BCG by Stimulating a Balanced Combination of Type 1 and Type 17 Cytokine ResponsesDESEL, Christiane; DORHOI, Anca; BANDERMANN, Silke et al.The Journal of infectious diseases. 2011, Vol 204, Num 10, pp 1573-1584, issn 0022-1899, 12 p.Article

BCGite après une revaccination accidentelle par le BCG = A persistent ulcération after a fortuitous BCG revaccinationCUCHET, E; TEMPLIER, I; BRION, J.-P et al.Annales de dermatologie et de vénéréologie. 2004, Vol 131, Num 12, pp 1077-1079, issn 0151-9638, 3 p.Article

IDR à l'école, BCG, PIT : La tuberculose = Intradermoreaction and tuberculosis immuzisation at schoolCOLLIGNON, H.Médecine & enfance. 2001, Vol 21, Num 7, pp 341-345, issn 0291-0233, 1Article

BCG: état actuel = BCG to dayPAPILLON, F.La Revue du praticien (Paris). 1984, Vol 34, Num 31, pp 1695-1701, issn 0035-2640Article

BCG : vaccination généralisée ou ciblée ?COHEN, R.Médecine & enfance. 2005, Vol 25, Num 1, pp 15-16, issn 0291-0233, 2 p., CAH1Article

Does isopathic phenomenon occur in leprosy?SARDARI LAL; NATARAJAN, S; VELIATH, A. J et al.Leprosy in India. 1983, Vol 55, Num 3, pp 495-499, issn 0024-1024Article

Dose-Finding Study of the Novel Tuberculosis Vaccine, MVA85A, in Healthy BCG-Vaccinated InfantsSCRIBA, Thomas J; TAMERIS, Michele; MULENGA, Humphrey et al.The Journal of infectious diseases. 2011, Vol 203, Num 12, pp 1832-1843, issn 0022-1899, 12 p.Article

Causes of variation in BCG vaccine efficacy: Examining evidence from the BCG REVAC cluster randomized trial to explore the masking and the blocking hypothesesBARRETO, Mauricio L; PILGER, Daniel; PEREIRA, Susan M et al.Vaccine. 2014, Vol 32, Num 30, pp 3759-3764, issn 0264-410X, 6 p.Article

The establishment of sub-strain specific WHO Reference Reagents for BCG vaccineDAGG, Belinda; HOCKLEY, Jason; RIGSBY, Peter et al.Vaccine. 2014, Vol 32, Num 48, pp 6390-6395, issn 0264-410X, 6 p.Article

Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trialsARBUES, Ainhoa; AGUILOA, Juan I; AUSINA, Vicente et al.Vaccine. 2013, Vol 31, Num 42, pp 4867-4873, issn 0264-410X, 7 p.Article

Evaluation of a Human BCG Challenge Model to Assess Antimycobacterial Immunity Induced by BCG and a Candidate Tuberculosis Vaccine, MVA85A, Alone and in CombinationHARRIS, Stephanie A; MEYER, Joel; SATTI, Iman et al.The Journal of infectious diseases. 2014, Vol 209, Num 8, pp 1259-1268, issn 0022-1899, 10 p.Article

Vaccination BCG : Allègement des obligations vaccinales = BCG vaccination : Reduction of vaccine obligationsLa Revue Prescrire. 2004, Vol 24, Num 253, issn 0247-7750, p. 628Article

Il faut continuer à vacciner par le BCG = It is necessary to continue to vaccinate with the BCGOLIVIER, C.Gazette médicale de France (1969). 1988, Num 32, pp 27-33, issn 0016-5557, 4 p.Article

Quelle place pour le BCG en France ? = What place for BCG vaccination in France?LEVY-BRUHL, D.Archives de pédiatrie (Paris). 2002, Vol 9, Num 1, pp 1-3, issn 0929-693XArticle

Characterization of BCG vaccine by coulter counter and scanning electron microscopic techniquesGROVES, M. J; KLEGERMAN, M. E; DEVADOSS, P. O et al.Particle & particle systems characterization. 1991, Vol 8, Num 3, pp 194-199, issn 0934-0866Article

Enhanced protection against tuberculosis by vaccination with recombinant BCG over-expressing HspX proteinCHUNWEI SHI; LINGXIA CHEN; ZHENHUA CHEN et al.Vaccine. 2010, Vol 28, Num 32, pp 5237-5244, issn 0264-410X, 8 p.Article

Targeted induction of antigen expression within dendritic cells modulates antigen-specific immunity afforded by recombinant BCGKONG, Carlyn U; LAI GUAN NG; NAMBIAR, Jonathan K et al.Vaccine. 2011, Vol 29, Num 7, pp 1374-1381, issn 0264-410X, 8 p.Article

Safety and reactogenicity of BCG revaccination with isoniazid pretreatment in TST positive adultsHATHERILL, Mark; GELDENHUYS, Hendrik; PIENAAR, Bernadette et al.Vaccine. 2014, Vol 32, Num 31, pp 3982-3988, issn 0264-410X, 7 p.Article